YTHDF2 promoted tumorigenesis of acute myeloid leukemia (AML) through recognizing m6A on, and promoting degradation of, TNFR2 mRNA, resulting in reduced sensitivity of AML Cells to TNF21. The gene discussed is YTHDF2; the disease is acute myeloid leukemia.